KeywordsHeteromeles arbutifolia; toyon; California holly; Alzheimer’s disease; phytochemistry; safety; Heliotropium strigosum; antimicrobial activity; cytotoxicity; phytotoxicity; antioxidant activity; Boraginaceae family; Lippia alba; essential oil; cytotoxic activity; antimicrobial activity; antidermatophytic; dermatophytes; DPPH; Lichen; Anogeissus leiocarpus; Chromobacterium violaceum CV026; Pseudomonas aeruginosa PAO1; pyocyanin; quorum sensing; essential oils (EOs); cytotoxicity; apoptosis; antioxidants; cell lines; anti-cancer activity; Oncoba spinosa; Flacourtin; cytotoxicity; Flacourtiaceae; phenolic ester glycoside; Terminalia mantaly; Combretaceae; anti-yeast; enzyme inhibitors; Chinese herbal medicine; diminished ovarian reserve; infertility; in vitro fertilization; uterus fibrosis; Neuropsychiatry; phytotherapy; traditional healers; Burkina Faso; ethno-medicinal uses; pharmacological activities; phytochemical profile; Sphenocentrum jollyanum Pierre; Marrubium vulgare L. herb; diabetes mellitus type 2; clinical trial; methodology; banana; Musa sapientum; hepatotoxicity; nephrotoxicity; wistar rat; rats; n/a
